Quarterly Result31 Oct 2025, 01:05 pm
Jubilant Pharmova Ltd Announces Q2 and Half-Year Results for 2025
AI Summary
Jubilant Pharmova Ltd has announced the financial results for the quarter and half-year ended September 30, 2025. The company's revenue from operations stands at 1,146 million for Q2 and 595 million for H1 2025. The total income for Q2 is 602 million and 1,207 million for H1 2025. The profit before tax for Q2 is 65 million and 130 million for H1 2025. The net profit for the period from continuing operations is 41 million for Q2 and 80 million for H1 2025. The net profit for the period, including discontinued operations, is 58 million for Q2 and 107 million for H1 2025.
Key Highlights
- Revenue from operations for Q2 2025 is 1,146 million and 595 million for H1 2025.
- Total income for Q2 2025 is 602 million and 1,207 million for H1 2025.
- Profit before tax for Q2 2025 is 65 million and 130 million for H1 2025.
- Net profit for the period from continuing operations is 41 million for Q2 and 80 million for H1 2025.
- Net profit for the period, including discontinued operations, is 58 million for Q2 and 107 million for H1 2025.